Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Debiopharm Innovation Fund S.A.

Part of Debiopharm Group™ – a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management – Debiopharm Innovation Fund’s mission is to invest in companies developing innovative therapeutics, diagnostics and smart data solutions that change the way we develop drugs and treat patients. Since 2008, the company has invested nearly USD 100 million and led 10 out of the 14 last investment rounds in its portfolio companies. *

 

Period Start 2008-01-01 established
  Group Debiopharm (Group)
Products Industry venture capital
  Industry 2 pharmaceutical
Person Person Dowe, Tanja (Debiopharm 201705 Head of Debiopharm Innovation Fund)
     
Region Region Switzerland_oo
  Country Switzerland
  City n. a. 
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 100,000,000 (capital invested 2017-05-09)
     
    * Document for »About Section«: 
     
   
Record changed: 2023-06-26

Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for Debiopharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top